【24h】

En Bloc Multivisceral and Kidney Transplantation in an HIV Patient: First Case Report

机译:艾滋病毒患者的整块多脏器和肾脏移植:第一例报告

获取原文
获取原文并翻译 | 示例
           

摘要

The continual improvement in outcome with highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV) infection and visceral transplantation for gut failure stimulated our interest in lifting HIV infection as a contraindication for intestinal and multivisceral transplantation. This report is the first to describe visceral transplantation in a patient with HIV infection. A HAART regimen was introduced in the setting of short-gut syndrome with successful suppression of HIV viral load. The indication for en bloc multivisceral and kidney transplantation was end-stage liver failure with portomesenteric venous thrombosis and chronic renal insufficiency. The underlying hepatic pathology was alcoholic and home parenteral nutrition associated cirrhosis. Surgery was complicated due to technical difficulties with excessive blood loss and long operative time. The complex posttransplant course included multiple exploratory laparotomies due to serious intra-abdominal and systemic infections. Heavy immunosuppression was required to treat recurrent episodes of severe allograft rejection. Posttransplant oral HAART successfully sustained undetectable viral load. Unfortunately, the patient succumbed to sepsis 3 months posttransplant. With new insights into the biology of gut immunity, mechanisms of allograft tolerance, and HIV-associated immune dysregulation, successful outcome is anticipated, particularly in patients who are in need of isolated intestinal and less-organ-contained visceral allografts.
机译:针对人类免疫缺陷病毒(HIV)感染的高活性抗逆转录病毒疗法(HAART)和针对肠道衰竭的内脏移植的结果不断提高,激发了我们对解除HIV感染作为肠和多内脏移植禁忌症的兴趣。该报告是第一个描述HIV感染患者内脏移植的报告。在成功抑制HIV病毒载量的短肠综合征中引入了HAART方案。整体多脏器和肾脏移植的适应症是终末期肝功能衰竭,并有肠系膜静脉血栓形成和慢性肾功能不全。潜在的肝病理是酒精和家庭肠外营养相关的肝硬化。由于技术上的困难,失血过多,手术时间长,手术复杂。由于严重的腹腔和全身感染,复杂的移植后过程包括多次探索性开腹手术。需要大量的免疫抑制来治疗严重同种异体移植排斥反应的复发发作。移植后口服HAART成功维持了不可检测的病毒载量。不幸的是,患者在移植后3个月屈服于败血症。随着对肠道免疫生物学,同种异体移植耐受性机制以及与HIV相关的免疫失调的新见解,有望获得成功的结果,尤其是在需要分离肠道和器官含量较低的内脏同种异体移植的患者中。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号